New study links COVID-19 to lasting neuropsychiatric issues, highlights vaccination benefits

FHS
June 27, 2024
5:08 am

COVID-19 survivors face significantly higher risks of developing neuropsychiatric conditions, but vaccination reduces these risks over time.

JMU Würzburg professor wins ERC Consolidator Grant to advance research on ferroptosis

With the coveted Consolidator Grants totalling two million euros, the European Research Council (ERC) supports outstanding scientists whose work promises further top achievements. José Pedro

November 23, 2023

Red Light Holland’s Todd Shapiro On Q2 and Cavan-Monaghan

It’s been a great summer for psychedelics news and we’re looking forward to fall in TDR’s latest Psychedelic exclusive. The CEO of Red Light Holland

September 7, 2023

FILAMENT HEALTH AND NASDAQ-LISTED SPAC JUPITER ACQUISITION CORP. ANNOUNCE FILING OF SEC REGISTRATION STATEMENT – Psychedelic Alpha

VANCOUVER, BC, Aug. 15, 2023 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company”), a clinical‐stage natural psychedelic drug development

August 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.